Enveric Biosciences, Inc. (ENVB)
1.40
-0.06
(-4.11%)
USD |
NASDAQ |
Nov 05, 16:00
1.40
0.00 (0.00%)
After-Hours: 20:00
Enveric Biosciences Net Income (TTM) : -8.729M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.729M |
| March 31, 2026 | -8.220M |
| December 31, 2025 | -8.772M |
| September 30, 2025 | -9.732M |
| June 30, 2025 | -9.943M |
| March 31, 2025 | -9.303M |
| December 31, 2024 | -9.575M |
| September 30, 2024 | -9.856M |
| June 30, 2024 | -10.59M |
| March 31, 2024 | -15.07M |
| December 31, 2023 | -17.29M |
| September 30, 2023 | -22.53M |
| June 30, 2023 | -22.19M |
| March 31, 2023 | -18.62M |
| December 31, 2022 | -18.47M |
| September 30, 2022 | -51.90M |
| June 30, 2022 | -52.13M |
| March 31, 2022 | -50.25M |
| December 31, 2021 | -48.98M |
| September 30, 2021 | -7.437M |
| June 30, 2021 | -5.543M |
| March 31, 2021 | -5.733M |
| September 30, 2020 | -5.011M |
| June 30, 2020 | -4.404M |
| March 31, 2020 | -4.842M |
| Date | Value |
|---|---|
| December 31, 2019 | -5.604M |
| September 30, 2019 | -22.84M |
| June 30, 2019 | -17.18M |
| March 31, 2019 | -17.19M |
| December 31, 2018 | -16.90M |
| September 30, 2018 | 1.843M |
| June 30, 2018 | -7.917M |
| March 31, 2018 | -9.921M |
| December 31, 2017 | -9.075M |
| September 30, 2017 | -6.747M |
| June 30, 2017 | -4.404M |
| March 31, 2017 | -2.349M |
| December 31, 2016 | -2.784M |
| September 30, 2016 | -5.840M |
| June 30, 2016 | -4.371M |
| March 31, 2016 | -3.051M |
| December 31, 2015 | -1.893M |
| September 30, 2015 | -0.1517M |
| June 30, 2015 | 0.0945M |
| March 31, 2015 | -0.0284M |
| December 31, 2014 | -0.0336M |
| September 30, 2014 | -0.01M |
| June 30, 2014 | -0.0113M |
| March 31, 2014 | -0.0033M |
| December 31, 2013 | -0.0002M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| LENZ Therapeutics, Inc. | -140.27M |
| Impact BioMedical, Inc. | 0.776M |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 159.33M |
| Veru, Inc. | -14.11M |